IRCT20200407046981N30尚未招募未知
Comparative bioequivalence study of the Pirfenidone 200-mg Tablets manufactured by Modava Pharmaceutical Company versus Pirfenex® (Cipla)
Modava pharmaceutical company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Pirfenidone or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two weeks before dosing.
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Pirfenidone tablet 200 mg Arang Pharma with brand drug (PIRFENEX® 200mg, Cipla, India)IRCT20200105046010N61Arang Pharm Co.24
招募中
不适用
Study of absorption and elimination rate of Biperiden 4-mg extended-release tablets in comparison with Biperiden brand tablets (Akineton®)IRCT20200407046981N44Vana Darou Gostar Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of Pirfenidone 267mgThis study is performed on healthy volunteers..IRCT20200623047902N3Zistdaru Danesh Company24
已完成
Unknown
Comparative bioequivalence study of the Fexofenadine Hydrichloride 180 mg, tablet manufactured by Tasnim CompanyIRCT20130313012810N16Tasnim24
已完成
Unknown
Fexofenadine HCl tablet bioequivalenceBioequivalence study in healthy volunteers.IRCT20130313012810N33Amin Pharmaceutical Co24